Thomas Kim - 21 Oct 2021 Form 3 Insider Report for Enfusion, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Blake Nielsen, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
21 Oct 2021
Net transactions value
$0
Form type
3
Filing time
21 Oct 2021, 20:44:24 UTC
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENFN Class A Common Stock 845,588 21 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consist of restricted stock units awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units vest 50% on February 20, 2023 and 50% on February 20, 2024.

Remarks:

Exhibit 24 - Power of Attorney